Leap Therapeutics Stock News

Check these three penny stocks out for your watchlist right now The post Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April  appeared first on Penny Stocks to Buy, Picks, News and

Leap Therapeutics (NASDAQ: LPTX ) reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Leap Therapeutics beat estimated earnings by 9.09%, reporting an EPS of … Full story available on Benzinga.com

Leap Therapeutics press release (LPTX): Q4 GAAP EPS of -$0.10 beats by $0.01.Revenue of $0.38M (flat Y/Y) beats by $0.08M.CEO comment: "Following our public offering, we are well…

CAMBRIDGE, Mass., March 11, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2021. Leap Highlights:…

CAMBRIDGE, Mass., March 2, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer will present a corporate overview at…

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 7.14% and 14.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Leap Therapeutics, Inc. (NASDAQ:LPTX) with the stream of -2.79% also noticed, India Spirit Airlines, Inc. (NYSE:SAVE) encountered a rapid change of -3.16% in the last hour of Fridays trading session. The post Captivating Stock: Leap Therapeutics, Inc. (NASDAQ:LPTX), Spirit Airlines, Inc. (NYSE:SAVE) appeared first on Stocks Equity .

NEW YORK , Feb. 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTRM, ITUB, BE, SAVA, and LPTX. … Full story available on Benzinga.com

Leap Therapeutics, Inc. (NASDAQ:LPTX) with the stream of 7.54% also noticed, India Amplify Energy Corp. (NYSE:AMPY) encountered a rapid change of 1.19% in the last hour of Mondays trading session. The post Stock Buzzers: Leap Therapeutics, Inc. (NASDAQ:LPTX), Amplify Energy Corp. (NYSE:AMPY) appeared first on Stocks Equity .

CAMBRIDGE, Mass., Jan. 24, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Do

Positive clinical trial results are giving investors a reason to cheer.

Positive clinical trial results are giving investors a reason to cheer.

Leap Therapeutics Inc (NASDAQ: LPTX ) will present updated data from the DisTinGuish Phase 2a study of DKN-01 , in combination with tislelizumab in gastric or gastric gastroesophageal junction cancer (G/GEJ). Data will be shared at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Tislelizumab is BeiGene Ltd''s (NASDAQ: BGNE ) anti-PD-1 antibody. In first-line patients treated with DKN-01 combo therapy showed overall preliminary median progression-free survival (PFS) of 10.7 months. The Full story available on Benzinga.com